HIGHLIGHTS
- who: Hospital Vivian Pellas and collaborators from the Department of Surgery, Universidad Nacional Autu00f3noma de, Leu00f3n, Wake Forest University Institute for Regenerative Medicine, Winston-Salem, NC, USA have published the research work: Safety of Stromal Vascular Fraction Cell Therapy for Chronic Kidney Disease of Unknown Cause (Mesoamerican Nephropathy), in the Journal: (JOURNAL)
- what: The aim of this first-in-human, open-label study was to determine feasibility and safety, and to gain potential evidence of clinical utility, of a single infusion of autologous SVF cells administered via renal artery catheterization in patients with stages 3 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.